tiprankstipranks
Advertisement
Advertisement
Crinetics reports Q4 EPS ($1.29), consensus ($1.37)
PremiumThe FlyCrinetics reports Q4 EPS ($1.29), consensus ($1.37)
1M ago
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
Premium
Market News
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
2M ago
Crinetics price target raised to $84 from $75 at Stifel
Premium
The Fly
Crinetics price target raised to $84 from $75 at Stifel
2M ago
Crinetics upgraded to Buy from Neutral at Goldman Sachs
PremiumThe FlyCrinetics upgraded to Buy from Neutral at Goldman Sachs
3M ago
Crinetics price target raised to $87 from $80 at Morgan Stanley
Premium
The Fly
Crinetics price target raised to $87 from $80 at Morgan Stanley
3M ago
Crinetics price target lowered to $105 from $108 at Citizens
Premium
The Fly
Crinetics price target lowered to $105 from $108 at Citizens
3M ago
Crinetics 7.62M share Secondary priced at $45.95
PremiumThe FlyCrinetics 7.62M share Secondary priced at $45.95
3M ago
Crinetics Highlights Strong PALSONIFY Launch and Trial Progress
Premium
Company Announcements
Crinetics Highlights Strong PALSONIFY Launch and Trial Progress
3M ago
Crinetics Buy Rating: Derisked Atumelnant CAH Program and Outperforming Palsonify Launch Signal Undervalued Shares
Premium
Ratings
Crinetics Buy Rating: Derisked Atumelnant CAH Program and Outperforming Palsonify Launch Signal Undervalued Shares
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100